Eli Lilly and Company
COMPOUNDS AND METHODS TARGETING INTERLEUKIN-19
Last updated:
Abstract:
The present invention provides compounds and methods targeting human interleukin-19, including therapeutic antibodies, pharmaceutical compositions and diagnostic applications useful in the field of immune-mediated diseases including psoriasis, atopic dermatitis, psoriatic arthritis, bronchial asthma and diabetic nephropathy.
Status:
Application
Type:
Utility
Filling date:
17 Jun 2020
Issue date:
12 Nov 2020